2024 AAO-HNSF临床实践指南:吸入性过敏的免疫治疗

发布日期:
2024-02-27
英文标题:
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy
出处:
Otolaryngol Head Neck Surg.2024 Mar:170 Suppl 1:S1-S42.
摘要:
变应原免疫治疗(AIT)是通过临床评估和过敏试验选择的一种或多种过敏原的治疗性暴露,可减少过敏症状并诱导免疫耐受。吸入性过敏原的AIT常用的形式为皮下免疫治疗(SCIT)或舌下免疫治疗(SLIT)。本文主要针对吸入性过敏的免疫治疗提供循证指导建议。 展开

部分内容仅可在
临床指南app 查看下载

阅读免费指南
发送到邮箱

收藏

分享

评论
提交评论
dhh
2024.02.29
回复
挺不错的,可以免费看好多指南,值得使用
/ 没有更多了 /
上传者信息
小易
于2024-02-28上传
编者信息
美国耳鼻咽喉头颈外科学会

The American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) is the world's largest organization representing specialists who treat the ear, nose, throat, and related structures of the head and neck. The Academy represents more than 12,000 otolaryngologist—head and neck surgeons who diagnose and treat disorders of those areas. The medical disorders treated by our physicians are among the most common that afflict all Americans, young and old. They include chronic ear infection, sinusitis, snoring and sleep apnea, hearing loss, allergies and hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness, and head and neck cancer. The AAO-HNS Foundation works to advance the art, science, and ethical practice of otolaryngology-head and neck surgery through education, research, and lifelong learning

置顶